Johnson & Johnson Profit Margin

Johnson & Johnson (JNJ) currently reports a profit margin of 21.48% as of June 2026. That compares with 33.88% in the prior-year period — down 36.6% year over year. That is above the Healthcare sector average of 14.34%. Use the charts on this page to explore Johnson & Johnson's profit margin history and peer comparisons.

Johnson & Johnson's profit margin decreased from 33.88% to 21.48% — a 36.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Johnson & Johnson's profit margin of 21.48% is higher than the Healthcare sector average of 14.34%. That is roughly 49.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Johnson & Johnson's current 21.48% should be judged against Healthcare norms (sector average: 14.34%) and against JNJ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 21.48%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Johnson & Johnson, and consider following JNJ for alerts when major investors trade the stock.